MONOCLONAL ANTIBODY FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA

摘要

A mechanism of action, way of treatment, composition and related methods for using the way of treatment and composition for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia is provided. The composition generally comprises a anti-IL7R antibody "monoclonal antibody" and/or a fragment of the anti-IL7R antibody.